Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

AMS:PRX - Euronext Amsterdam - NL0013654783 - Common Stock - Currency: EUR

48.415  +0.3 (+0.63%)

Fundamental Rating

6

Overall PRX gets a fundamental rating of 6 out of 10. We evaluated PRX against 10 industry peers in the Broadline Retail industry. PRX has an excellent financial health rating, but there are some minor concerns on its profitability. PRX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

PRX had positive earnings in the past year.
PRX had a positive operating cash flow in the past year.
Each year in the past 5 years PRX has been profitable.
The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

The Return On Assets of PRX (17.04%) is better than 90.00% of its industry peers.
The Return On Equity of PRX (24.23%) is better than 70.00% of its industry peers.
PRX has a Return On Invested Capital of 0.21%. This is in the lower half of the industry: PRX underperforms 70.00% of its industry peers.
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROIC 0.21%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

The Profit Margin of PRX (200.44%) is better than 90.00% of its industry peers.
PRX's Profit Margin has improved in the last couple of years.
PRX has a worse Operating Margin (3.05%) than 80.00% of its industry peers.
The Gross Margin of PRX (42.53%) is worse than 60.00% of its industry peers.
PRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRX is destroying value.
The number of shares outstanding for PRX has been reduced compared to 1 year ago.
Compared to 5 years ago, PRX has more shares outstanding
The debt/assets ratio for PRX has been reduced compared to a year ago.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

PRX has an Altman-Z score of 4.83. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
PRX has a better Altman-Z score (4.83) than 70.00% of its industry peers.
PRX has a debt to FCF ratio of 9.30. This is a negative value and a sign of low solvency as PRX would need 9.30 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.30, PRX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that PRX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.30, PRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 4.83
ROIC/WACC0.03
WACC7.6%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 3.54 indicates that PRX has no problem at all paying its short term obligations.
The Current ratio of PRX (3.54) is better than 100.00% of its industry peers.
PRX has a Quick Ratio of 3.50. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
PRX has a Quick ratio of 3.50. This is amongst the best in the industry. PRX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.5
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

6

3. Growth

3.1 Past

PRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.26%, which is quite impressive.
PRX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.24% yearly.
PRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.86%.
The Revenue has been growing by 13.13% on average over the past years. This is quite good.
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%

3.2 Future

PRX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.24% yearly.
Based on estimates for the next years, PRX will show a quite strong growth in Revenue. The Revenue will grow by 12.80% on average per year.
EPS Next Y19.75%
EPS Next 2Y17.74%
EPS Next 3Y-6.24%
EPS Next 5YN/A
Revenue Next Year13.62%
Revenue Next 2Y13.08%
Revenue Next 3Y12.8%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

PRX is valuated reasonably with a Price/Earnings ratio of 10.93.
Based on the Price/Earnings ratio, PRX is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of PRX to the average of the S&P500 Index (27.30), we can say PRX is valued rather cheaply.
A Price/Forward Earnings ratio of 14.29 indicates a correct valuation of PRX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRX indicates a somewhat cheap valuation: PRX is cheaper than 70.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. PRX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.93
Fwd PE 14.29
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRX is valued a bit more expensive than 70.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 76.15
EV/EBITDA 359.36
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRX's earnings are expected to decrease with -6.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.55
PEG (5Y)0.63
EPS Next 2Y17.74%
EPS Next 3Y-6.24%

More info and screens

3

5. Dividend

5.1 Amount

PRX has a yearly dividend return of 0.21%, which is pretty low.
PRX's Dividend Yield is a higher than the industry average which is at 1.37.
With a Dividend Yield of 0.21, PRX pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.21%

5.2 History

The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PRX pays out 2.17% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of PRX has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP2.17%
EPS Next 2Y17.74%
EPS Next 3Y-6.24%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

More info and screens

PROSUS NV

AMS:PRX (7/11/2025, 7:00:00 PM)

48.415

+0.3 (+0.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)06-23 2025-06-23/amc
Earnings (Next)11-24 2025-11-24
Inst Owners63.56%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap115.18B
Analysts78.33
Price Target56.34 (16.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.21%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.75%
PT rev (3m)6.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 10.93
Fwd PE 14.29
P/S 21.81
P/FCF 76.15
P/OCF 71.84
P/B 2.64
P/tB 2.72
EV/EBITDA 359.36
EPS(TTM)4.43
EY9.15%
EPS(NY)3.39
Fwd EY7%
FCF(TTM)0.64
FCFY1.31%
OCF(TTM)0.67
OCFY1.39%
SpS2.22
BVpS18.37
TBVpS17.81
PEG (NY)0.55
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROCE 0.28%
ROIC 0.21%
ROICexc 0.3%
ROICexgc 0.31%
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
FCFM 28.64%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 45.16
Cap/Depr 72.6%
Cap/Sales 1.72%
Interest Coverage 0.36
Cash Conversion 560.78%
Profit Quality 14.29%
Current Ratio 3.54
Quick Ratio 3.5
Altman-Z 4.83
F-Score6
WACC7.6%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
EPS Next Y19.75%
EPS Next 2Y17.74%
EPS Next 3Y-6.24%
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%
Revenue Next Year13.62%
Revenue Next 2Y13.08%
Revenue Next 3Y12.8%
Revenue Next 5YN/A
EBIT growth 1Y212.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year228.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y181.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.5%
OCF growth 3YN/A
OCF growth 5YN/A